New hope for Tough-to-Treat lymphoma: experimental drug cocktail enters human testing

NCT ID NCT05169515

Recruiting now Disease control Sponsor: Hoffmann-La Roche Source: ClinicalTrials.gov ↗

Summary

This early-stage study is testing the safety and initial effectiveness of combining two different types of immunotherapy drugs for people with B-cell non-Hodgkin lymphoma that has come back or stopped responding to standard treatments. The trial will enroll about 121 adults who have already tried at least one or two prior therapies. Researchers aim to find the best doses and see if these combinations can help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ASST Spedali Civili di Brescia
RECRUITING

Brescia, Lombardy, 25123, Italy
Azienda Ospedaliero Universitaria Pisana-Ospedale Santa Chia
RECRUITING

Pisa, Piedmont, 56126, Italy
Center Hospital
RECRUITING

Ramat Gan, 5262199, Israel
Clinica Universidad de Navarra-Madrid
RECRUITING

Madrid, 28027, Spain
Hadassah University Hospital - Ein Kerem
RECRUITING

Jerusalem, 9112001, Israel
Hosp Universitario Salamanca
RECRUITING

Salamanca, 37007, Spain
Hospital General Universitario Gregorio Maranon
RECRUITING

Madrid, 28040, Spain
Hospital Universitari Vall d Hebron
RECRUITING

Barcelona, 08035, Spain
Hospital Universitario La Fe
RECRUITING

Valencia, Valencia, 46026, Spain
ICO L'Hospitalet
RECRUITING

L'Hospitalet de Llobregat, Barcelona, 08908, Spain
IRCCS Azienda Ospedaliero Universitaria di Bologna
RECRUITING

Bologna, Emilia-Romagna, 40138, Italy
IRCCS Istituto Romagnolo per lo studio dei tumori "Dino Amadori"
RECRUITING

Meldola, Emilia-Romagna, 47014, Italy
Irccs Ospedale San Raffaele
RECRUITING

Milan, Lombardy, 20132, Italy
Levine Cancer Institute
RECRUITING

Charlotte, North Carolina, 28204, United States
Moffitt Cancer Center
RECRUITING

Tampa, Florida, 33612, United States
NHS Greater Glasgow and Clyde
RECRUITING

Glasgow, G12 0YN, United Kingdom
Nottingham University Hospitals City Campus
RECRUITING

Nottingham, NG5 1PB, United Kingdom
Oxford University Hospitals NHS Trust - Churchill Hospital
RECRUITING

Oxford, OX3 7LE, United Kingdom
Rambam Health Care Campus
RECRUITING

Haifa, 3109600, Israel
Soroka
RECRUITING

Beersheba, 0084101, Israel
Sourasky Medical Center
RECRUITING

Tel Aviv, 6423900, Israel
The University of Chicago
RECRUITING

Chicago, Illinois, 60637, United States
UCSF/Hematology, Blood & Marrow Transplant, And Cellular Therapy (HBC) Program
RECRUITING

San Francisco, California, 94143, United States
UT MD Anderson Cancer Center
RECRUITING

Houston, Texas, 77030, United States
University College London Hospitals
RECRUITING

London, W1T 7HA, United Kingdom
University of Colorado
RECRUITING

Aurora, Colorado, 80045, United States

Conditions

Explore the condition pages connected to this study.

NON-HODGKIN LYMPHOMA